Terms: = Lung cancer AND SDHA, SDH2, 6389, ENSG00000073578, FP, P31040, SDHF AND Prognosis
25 results:
1. Nanoparticles targeting mutant p53 overcome chemoresistance and tumor recurrence in non-small cell lung cancer.
Bi YY; Chen Q; Yang MY; Xing L; Jiang HL
Nat Commun; 2024 Mar; 15(1):2759. PubMed ID: 38553451
[TBL] [Abstract] [Full Text] [Related]
2. Frozen sections accurately predict the IASLC proposed grading system and prognosis in patients with invasive lung adenocarcinomas.
Fan J; Yao J; Si H; Xie H; Ge T; Ye W; Chen J; Yin Z; Zhuang F; Xu L; Su H; Zhao S; Xie X; Zhao D; Wu C; Zhu Y; Ren Y; Xu N; Chen C;
Lung Cancer; 2023 Apr; 178():123-130. PubMed ID: 36822017
[TBL] [Abstract] [Full Text] [Related]
3. PSMA1, a Poor Prognostic Factor, Promotes Tumor Growth in lung Squamous Cell Carcinoma.
Liu Z; Wang W; Zhou Y; Li L; Zhou W
Dis Markers; 2023; 2023():5386635. PubMed ID: 36776923
[TBL] [Abstract] [Full Text] [Related]
4. Comprehensive Analysis of the Molecular Characteristics and prognosis value of AT II-associated Genes in Non-small Cell lung cancer.
Ren L; Wen X; Liu M; Xiao Y; Leng P; Luo H; Tao P; Xie L
Comput Math Methods Med; 2022; 2022():3106688. PubMed ID: 36203529
[TBL] [Abstract] [Full Text] [Related]
5. Comparison of Efficacy and Safety of Taxanes Plus Platinum and Fluorouracil Plus Platinum in the First-Line Treatment of Esophageal cancer: A Systematic Review and Meta-Analysis.
Zhao Y; Song R; Jia Y; Zhang X; Zhang S; Wu C; Zhang R; Guo Z
Curr Oncol; 2022 Sep; 29(9):6610-6627. PubMed ID: 36135088
[TBL] [Abstract] [Full Text] [Related]
6. Long non-coding RNA
Hao X; Zhang M; Gu M; Wang Z; Zhou S; Li W; Xu S
PeerJ; 2022; 10():e13871. PubMed ID: 36032951
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic Evaluation of CT Imaging Big Data-Assisted Arterial Chemoembolization Combined with
Xie P; Zhang Y; He L
Comput Math Methods Med; 2022; 2022():3472982. PubMed ID: 35872936
[TBL] [Abstract] [Full Text] [Related]
8.
Chen S; Zhang W; Yuan D; Yu W; Ye X; Ling C
Genet Test Mol Biomarkers; 2022 Jun; 26(6):340-347. PubMed ID: 35763382
[No Abstract] [Full Text] [Related]
9. Serine hydroxymethyltransferase 2 expression promotes tumorigenesis in rhabdomyosarcoma with 12q13-q14 amplification.
Nguyen TH; Vemu PL; Hoy GE; Boudjadi S; Chatterjee B; Shern JF; Khan J; Sun W; Barr FG
J Clin Invest; 2021 Aug; 131(15):. PubMed ID: 34166228
[TBL] [Abstract] [Full Text] [Related]
10. FOXF1 is required for the oncogenic properties of PAX3-FOXO1 in rhabdomyosarcoma.
Milewski D; Shukla S; Gryder BE; Pradhan A; Donovan J; Sudha P; Vallabh S; Pyros A; Xu Y; Barski A; Szabo S; Turpin B; Pressey JG; Millay DP; Khan J; Kalinichenko VV; Kalin TV
Oncogene; 2021 Mar; 40(12):2182-2199. PubMed ID: 33627785
[TBL] [Abstract] [Full Text] [Related]
11. Overexpression of GSDMC is a prognostic factor for predicting a poor outcome in lung adenocarcinoma.
Wei J; Xu Z; Chen X; Wang X; Zeng S; Qian L; Yang X; Ou C; Lin W; Gong Z; Yan Y
Mol Med Rep; 2020 Jan; 21(1):360-370. PubMed ID: 31939622
[TBL] [Abstract] [Full Text] [Related]
12. Phosphatidylserine: A cancer cell targeting biomarker.
Sharma B; Kanwar SS
Semin Cancer Biol; 2018 Oct; 52(Pt 1):17-25. PubMed ID: 28870843
[TBL] [Abstract] [Full Text] [Related]
13. lung neuroendocrine tumours: deep sequencing of the four World Health Organization histotypes reveals chromatin-remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D.
Simbolo M; Mafficini A; Sikora KO; Fassan M; Barbi S; Corbo V; Mastracci L; Rusev B; Grillo F; Vicentini C; Ferrara R; Pilotto S; Davini F; Pelosi G; Lawlor RT; Chilosi M; Tortora G; Bria E; Fontanini G; Volante M; Scarpa A
J Pathol; 2017 Mar; 241(4):488-500. PubMed ID: 27873319
[TBL] [Abstract] [Full Text] [Related]
14. Precise Diagnosis of Intraoperative Frozen Section Is an Effective Method to Guide Resection Strategy for Peripheral Small-Sized lung Adenocarcinoma.
Liu S; Wang R; Zhang Y; Li Y; Cheng C; Pan Y; Xiang J; Zhang Y; Chen H; Sun Y
J Clin Oncol; 2016 Feb; 34(4):307-13. PubMed ID: 26598742
[TBL] [Abstract] [Full Text] [Related]
15. [Long-term survival of a patient with esophageal cancer with brain metastasis after multidisciplinary therapy - a case report].
Yamamoto Y; Tanaka H; Maruyama T; Matsuzaki H; Natsume T; Miyazaki A; Satoh Y; Satsuka T; Yoshioka T; Kanada Y; Otsuka R; Yanagihara A; Yokoyama M; Kobayashi T
Gan To Kagaku Ryoho; 2014 Nov; 41(12):2006-9. PubMed ID: 25731404
[TBL] [Abstract] [Full Text] [Related]
16. Genetic variants in genes of tricarboxylic acid cycle key enzymes are associated with prognosis of patients with non-small cell lung cancer.
Guo X; Li D; Wu Y; Chen Y; Zhou X; Wang X; Huang X; Li X; Yang H; Xing J
Lung Cancer; 2015 Feb; 87(2):162-8. PubMed ID: 25576295
[TBL] [Abstract] [Full Text] [Related]
17. Predictors of survival for younger patients less than 50 years of age with non-small cell lung cancer (NSCLC): a California cancer Registry analysis.
Lara MS; Brunson A; Wun T; Tomlinson B; Qi L; Cress R; Gandara DR; Kelly K
Lung Cancer; 2014 Aug; 85(2):264-9. PubMed ID: 24878033
[TBL] [Abstract] [Full Text] [Related]
18. Computer-aided detection system for lung cancer in computed tomography scans: review and future prospects.
Firmino M; Morais AH; Mendoça RM; Dantas MR; Hekis HR; Valentim R
Biomed Eng Online; 2014 Apr; 13():41. PubMed ID: 24713067
[TBL] [Abstract] [Full Text] [Related]
19. False-positivity of mediastinal lymph nodes has negative effect on survival in potentially resectable non-small cell lung cancer.
Iskender I; Kadioglu SZ; Cosgun T; Kapicibasi HO; Sagiroglu G; Kosar A; Kir A
Eur J Cardiothorac Surg; 2012 Apr; 41(4):874-9. PubMed ID: 22423060
[TBL] [Abstract] [Full Text] [Related]
20. Surgical intervention following imatinib treatment in patients with advanced gastrointestinal stromal tumors (GISTs).
Sym SJ; Ryu MH; Lee JL; Chang HM; Kim TW; Kim HC; Kim KH; Yook JH; Kim BS; Kang YK
J Surg Oncol; 2008 Jul; 98(1):27-33. PubMed ID: 18452195
[TBL] [Abstract] [Full Text] [Related]
[Next]
